Last update 23 Jan 2025

111 In-FF-21101

Overview

Basic Info

Drug Type
Antibody toxin conjugate, Therapeutic radiopharmaceuticals
Synonyms
Target
CDH3
Mechanism
CDH3 inhibitors(Cadherin 3 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication
Advanced cancerAdvanced Malignant Solid NeoplasmBile Duct Neoplasms+ [6]
Originator Organization
FUJIFILM Toyama Chemical Co., Ltd.FUJIFILM Toyama Chemical Co., Ltd.
Active Organization
Chiba UniversityChiba UniversityFUJIFILM Toyama Chemical Co., Ltd.FUJIFILM Toyama Chemical Co., Ltd.
Inactive Organization
FUJIFILM Pharmaceuticals USA, Inc.
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with 111 In-FF-21101
NCT02454010
/ CompletedPhase 1
A Phase 1 Dose-escalation Study of Radio- Labeled Antibody, FF-21101(90Y) for the Treatment of Advanced Cancer
100 Clinical Results associated with 111 In-FF-21101
Login to view more data
100 Translational Medicine associated with 111 In-FF-21101
Login to view more data
100 Patents (Medical) associated with 111 In-FF-21101
Login to view more data
100 Deals associated with 111 In-FF-21101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
Advanced Malignant Solid NeoplasmPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
Bile Duct NeoplasmsPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
Colorectal CancerPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
Fallopian Tube CarcinomaPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
Gallbladder CarcinomaPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
Pancreatic CancerPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
Squamous Cell Carcinoma of Head and NeckPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
Triple Negative Breast CancerPhase 1
US
FUJIFILM Pharmaceuticals USA, Inc.
01 Jan 2016
NeoplasmsPreclinical
JP
FUJIFILM Toyama Chemical Co., Ltd.FUJIFILM Toyama Chemical Co., Ltd.
31 Jul 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free